Specifically, the copy numbers or expression levels of various HCC-associated oncogenes and suppressors, such as TP53, TERT, and ARID1A, have been assessed for the early detection and prognosis monitoring of HCC [41,42,43,44]. This evidence concerns the gene ARID1A and hepatocellular carcinoma.